Cyclophosphamide (International)
In the US, Cyclophosphamide (cyclophosphamide systemic) is a member of the drug class alkylating agents and is used to treat Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Cogan's Syndrome, Dermatomyositis, Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Ewing's Sarcoma, Granulomatosis with Polyangiitis, Histiocytosis, Hodgkin's Lymphoma, Lupus, Lupus Nephritis, Mantle Cell Lymphoma, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neuroblastoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Organ Transplant - Rejection Prophylaxis, Osteosarcoma, Ovarian Cancer, Pemphigoid, Pemphigus, Primary Immunoglobulin A Nephropathy, Prostate Cancer, Rheumatoid Arthritis, Scleroderma, Small Cell Lung Cancer, Systemic Sclerosis, Testicular Cancer and Wilms' Tumor.
US matches:
- Cyclophosphamide oral and injection
- Cyclophosphamide
- Cyclophosphamide Capsules
- Cyclophosphamide Tablets
- Cyclophosphamide Concentrate Injection
- Cyclophosphamide Injection
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01AA01
CAS registry number (Chemical Abstracts Service)
0000050-18-0
Chemical Formula
C7-H15-Cl2-N2-O2-P
Molecular Weight
261
Therapeutic Categories
Disease-modifying antirheumatic drug, DMARD
Cytostatic alkylating agent
Chemical Name
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroetyl)tetrahydro-, 2-oxide
Foreign Names
- Cyclophosphamidum (Latin)
- Cyclophosphamid (German)
- Cyclophosphamide (French)
- Ciclofosfamida (Spanish)
Generic Names
- Cyclophosphamide (OS: DCF, BAN)
- B 518 (IS)
- CYP (IS)
- Ledoxina (IS)
- NSC 26271 (IS)
- Cyclophosphamide (PH: Ph. Eur. 9, Ph. Int. 7, USP 41)
- Cyclophosphamide Hydrate (OS: JAN)
- Ciclofosfamide (PH: Ph. Eur. 9)
- Cyclophosphamid (PH: Ph. Eur. 9)
- Cyclophosphamide (PH: BP 2018)
- Cyclophosphamide Hydrate (PH: JP XVII)
- Cyclophosphamidum (PH: Ph. Eur. 9, Ph. Int. 7)
Brand Names
- Alkyloxan
Human Care, Egypt - Biodoxan
Biogalenic, Venezuela - Ciclofosfamida
LKM Peru, Peru; Palmagyar, Peru; Perulab, Peru - Ciclofosfamida 1000 DOSA
DOSA, Paraguay - Ciclofosfamida 1000mg Martian
Kampel Martian, Paraguay - Ciclofosfamida Dosa
Dosa, Argentina; Dosa, Uruguay - Ciclofosfamida Farmaco
Farmaco Urug., Paraguay - Ciclofosfamida Filaxis
GP Pharm, Argentina - Ciclofosfamida FU
FU, Uruguay - Ciclofosfamida Kampar
Laboratorio Kampar, Chile - Ciclofosfamida Kemex
Kemex, Argentina - Ciclofosfamida Lafedar
Lafedar, Argentina - Ciclofosfamida LKM 1000
LKM, Argentina - Ciclofosfamida Microsules
Microsules Arg, Argentina - Ciklofosfamid Sandoz
Sandoz, Croatia (Hrvatska) - Clyclomide
Pharmedic, Pakistan - Cyclocel
Celon, Georgia - Cyclofosfamide Cadiasun
Cadiasun, Netherlands - Cyclofosfamide Sandoz
Sandoz, Netherlands - Cyclomide
Pharmedic, Pakistan - Cyclophosphamid Sandoz 1000 mg
Sandoz, Hungary - Cyclophosphamid Sandoz 500 mg
Sandoz, Hungary - Cyclophosphamide
Baxter Healthcare, United States; IBL Healthcare, Pakistan; Jiangsu Hengrui, United States; West-Ward, United States - Cyclophosphamide - Hisun Pharm
Hisun Pfizer Pharmaceuticals, China - Cyclophosphamide Baxter
Baxter, New Zealand; Baxter Healthcare, Malta - Cyclophosphamide Kalbe
Kalbe, Indonesia - Cyclophosphamide-Hisun Pharm
Hisun Pfizer Pharmaceuticals, China - Cyclophosphan
Rue Belmedpreparaty, Georgia - Cyclovid
Novell Pharmaceutical, Indonesia - Cycram
Dbl, Egypt; Korea United, Hong Kong; Korea United Pharm., Vietnam - Cytoxan
Bristol-Myers Squibb, Lithuania - Demacylan
Sandoz, Poland - Endoxan
Almirall, Russian Federation; ASTA Medica, Kuwait; ASTA Medica, Pakistan; Baxter, Bosnia & Herzegowina; Baxter, Chile; Baxter, Cyprus; Baxter, Ecuador; Baxter, Egypt; Baxter, France; Baxter, Lithuania; Baxter, Latvia; Baxter, New Zealand; Baxter, Oman; Baxter, Poland; Baxter, Thailand; Baxter, Tunisia; Baxter, Taiwan; Baxter Belgium, Belgium; Baxter Oncology, Germany; Baxter Oncology, Lebanon; Baxter Oncology, Singapore; Eczacibasi Baxter, Turkey; IFET, Greece; Lex ano, Lithuania; Sanofi-Aventis, South Africa; Transfarma Medica Indah, Indonesia; Baxter Healthcare Trading Shanghai, China - Endoxan 1g
Baxter, Luxembourg; Baxter Oncology, Israel - Endoxan 200mg
Baxter, Luxembourg - Endoxan 500mg
Baxter, Luxembourg; Baxter Oncology, Israel - Endoxan 50mg
Baxter, Luxembourg - Endoxana
Baxter, Egypt; Baxter, Lebanon - Endoxan-Asta
Zydus, India - Genoxal
Baxter, Spain - Genuxal
Baxter, Brazil - Hidrofosmin
Sanfer, Mexico - Ledoxan
Fresenius, Philippines - Ledoxina
Lemery, Lithuania - Neophos
Cipla, Lebanon - Procytox
Baxter, Canada; Clinect, New Zealand - Sendoxan
Baxter, Denmark; Baxter Medical AB, Iceland - Syklofosfamid
Atafarm, Turkey; Orion, Taiwan - Vf
Human Care, Egypt - Xyclomed
Korea United Pharma, Philippines - Cryofaxol
Cryopharma, Mexico - Cyclonex
Zenex, Australia - Cyclophosphamid HEXAL
Hexal, Germany - Cyclophosphamide
Baxter Healthcare, United Kingdom; Sandoz, United Kingdom; Teva, Lithuania - Cyclophosphamide Sandoz
Sandoz, France - Cyclophosphamide Sandoz 1000 mg
Sandoz, Austria - Cyclophosphamide Sandoz 2000 mg
Sandoz, Austria - Cyclophosphamide Sandoz 500 mg
Sandoz, Austria - Demacylan
Ebewe Pharma, Macedonia - Endoxan
Actavis, Romania; Agmar, Croatia (Hrvatska); Baxter, Czech Republic; Baxter, France; Baxter, Hong Kong; Baxter, Hungary; Baxter, Portugal; Baxter, Romania; Baxter, Slovakia; Baxter Healthcare, Australia; Baxter Nederland, Netherlands; Baxter Oncology, Estonia; Baxter Oncology, Macedonia; Baxter Oncology GmbH, Serbia; Dr. Fisher Farma, Netherlands; Shionogi Seiyaku, Japan - Endoxan 1 g
Baxter, Hungary - Endoxan 1g
Baxter, Switzerland; Baxter Oncology, Bulgaria - Endoxan 200mg
Baxter, Switzerland; Baxter Oncology, Bulgaria - Endoxan 500 mg
Baxter, Hungary - Endoxan 500mg
Baxter, Switzerland; Baxter Oncology, Bulgaria - Endoxan 50mg
Baxter, Switzerland; Baxter Oncology, Bulgaria - Endoxan Baxter
Baxter-RM, Italy - Endoxan Baxter 1 g
Baxter Healthcare, Austria - Endoxan Baxter 200 mg
Baxter Healthcare, Austria - Endoxan Baxter 50 mg
Baxter Healthcare, Austria - Endoxan Baxter 500 mg
Baxter Healthcare, Austria - Endoxana
Baxter, Ireland - Formitex
Pisa, Mexico - Formitex Pisa
Pisa, Colombia - Ledoxina
Teva, Mexico - Sendoxan
Baxter, Finland; Baxter, Norway; Baxter, Sweden
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
